吕万良和林瑞超团队在揭示五味子乙素抗男性不育基因调控机制方面取得进展

中国药学(英文版) ›› 2021, Vol. 30 ›› Issue (7): 615-616.

吕万良和林瑞超团队在揭示五味子乙素抗男性不育基因调控机制方面取得进展

北京大学药学院天然药物及仿生药物国家重点实验室

北京大学药学院天然药物及仿生药物国家重点实验室

收稿日期:2021-07-22 修回日期:2021-07-23 接受日期:2021-07-24 出版日期:2021-07-27 发布日期:2021-07-30

The research groups of Wanliang Lu and Ruichao Lin have made progress in revealing the regulatory mechanism of Schisandrin B for the treatment of male infertility

State Key Laboratory of Natural and Biomimetic Drugs, School of Pharmaceutical Sciences, Peking University Health Science Center

State Key Laboratory of Natural and Biomimetic Drugs, School of Pharmaceutical Sciences, Peking University Health Science Center

Received:2021-07-22 Revised:2021-07-23 Accepted:2021-07-24 Online:2021-07-27 Published:2021-07-30

摘要/Abstract

摘要：

近日, 北京大学药学院天然药物及仿生药物国家重点实验室吕万良教授团队和北京中医药大学中药品质评价北京市重点实验室林瑞超教授团队在国际著名学术期刊《Clinical and Translational Medicine》在线发表了题为“Schisandrin B for treatment of male infertility”的研究工作。

Supporting:

北京大学药学院天然药物及仿生药物国家重点实验室. 吕万良和林瑞超团队在揭示五味子乙素抗男性不育基因调控机制方面取得进展[J]. 中国药学(英文版), 2021, 30(7): 615-616.

State Key Laboratory of Natural and Biomimetic Drugs, School of Pharmaceutical Sciences, Peking University Health Science Center. The research groups of Wanliang Lu and Ruichao Lin have made progress in revealing the regulatory mechanism of Schisandrin B for the treatment of male infertility[J]. Journal of Chinese Pharmaceutical Sciences, 2021, 30(7): 615-616.